Email Facebook Twitter

Moosh's Blog - RSS Feed

Moosh's Blog


News for the Snoozers - Part 2

Beximco Pharma (TIDM: BXP)

Beximco Pharma has recently released third quarter results (Q3 2014)1 and it has continued to show a gradual growth in net profit with earnings per share (eps) of 3.14 Taka (Q1 to Q3 2014) which is 6.8% growth in earnings compared to 2013. The company still remains undervalued at 18.5p (mid-price close as of 7 November 2014)2. The net asset value of the company also increased to 55.85 Taka per share (46p/share, exchange rate on 8 November 2014).


Blog Calendar


News for the Snoozers, part 1

I thought I would begin a parallel thread of blog posts which gives a round-up of news which I obviously have an interest in due to my own investing habits..


Camco Clean Energy – a clean slate

Jam today? Well, not yet with Camco Clean Energy (TIDM:CCE).1 This one is still a ‘jam tomorrow’, but you know, jam takes a while to make.


Beximco Pharma - the case of the undervalued pharmaceutical company

I have been a long term shareholder in Beximco Pharma (TIDM: BXP), the AIM-listed manufacturer of generic pharmaceuticals in Bangladesh, which is also listed on the Dhaka and Chittagong stock exchanges.


Fantasy Yesterday, Reality Today

My previous blog post at the back end of 2013 questioned whether fantasy can turn into reality with respect to picking an undervalued company to invest in based on something as simple as the price to earnings (PE) ratio (amongst other factors).


Fantasy Today, Reality Tomorrow

Over the last few weeks, readers of this blog will have seen me try to tie the share price to earnings via a PE ratio based fair value price range (which I have assumed to exist between a broad PE ratio range of 10 and 20). 


Needles in Giant Haystacks

Let me stop you there before you begin to conjure up images of someone trying to vaccinate a wrestler from the 80s.


One Lump or Two?

What about AIM, the Alternative Investment Market?

Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.